main-img
Back to Home » February 2017 News » Vernalis achieves a $3 million milestone payment from Corvus Pharmaceuticals Inc

Vernalis achieves a $3 million milestone payment from Corvus Pharmaceuticals Inc

February 14, 2017

WINNERSH, UNITED KINGDOM--(Marketwired - Feb 14, 2017) - Vernalis plc (LSE: VER) is pleased to announce the achievement of a clinical milestone from its collaboration with Corvus Pharmaceuticals Inc ("Corvus") triggering a payment of $3 million to Vernalis.

Source URL: http://www.marketwired.com/mw/release.do?id=2195586&sourceType=3
Browse News